New progress with calcium-binding protein S100A16 in digestive system disease.

Area of Science:

• Gastroenterology and Hepatology
• Molecular Biology
• Oncology

Background:

• The S100A16 protein's role in digestive system diseases is increasingly recognized.
• Abnormal S100A16 expression is implicated in various gastrointestinal pathologies.
• This review focuses on S100A16's involvement in digestive tumors, inflammatory bowel disease, and fatty liver disease.

Approach:

• Comprehensive literature review of original publications from PubMed and Cochrane databases.
• Analysis of the molecular mechanisms underlying S100A16 dysregulation.
• Synthesis of current research on S100A16 in specific digestive system diseases.

Key Points:

• S100A16 significantly influences the proliferation, migration, and invasion of digestive system tumor cells.
• The protein plays a critical role in the pathogenesis of inflammatory bowel disease.
• S100A16 is implicated in the development and progression of fatty liver disease.

Conclusions:

• Abnormal S100A16 expression is a key factor in digestive system diseases.
• Further research into S100A16 mechanisms can offer novel therapeutic strategies.
• S100A16 may serve as a valuable biomarker for prognosis and treatment guidance in digestive disorders.